Peter Kolchinsky

Director

Peter Kolchinsky (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in VOR. The largest single filing was $14.5M of VOR (847,732 sh across 4 lots, as filed), executed Apr 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$25.9M

shares × price, as filed

Last traded

Jun 9

Filed Jun 11

Median ADV $10.0M across their filed names

Open performance→

Volume by month

Buys $215.5M Sells $25.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings Not on file 2 filings

Sector per market data · by filing · past 12 months

Most traded names

VOR VOR VOR · 0 buys · 2 sells 2 filings CDTX CDTX CDTX · 1 buy · 0 sells 1 filing ETNB ETNB ETNB · 1 buy · 0 sells 1 filing HOWL

Werewolf Therapeutics, Inc. HOWL · 0 buys · 1 sell 1 filing JANX JANX JANX · 1 buy · 0 sells 1 filing

Recent filings

HOWLSALE Werewolf Therapeutics, Inc. View filing → $128K
345,235 sh × $0.37
Exec Jun 9
Filed Jun 11 · 5:30 PM ET VORSALE Vor Biopharma Inc. View filing → $14.5M
847,732 sh across 4 lots
Exec Apr 2
Filed Apr 6 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. View filing → $947K
23,973 sh across 3 lots
Exec Nov 21 2025
Filed Nov 24 2025 · 5:30 PM ET VORSALE Vor Biopharma Inc. View filing → $10.4M
400,408 sh across 4 lots
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET CDTXPURCHASE Cidara Therapeutics, Inc. View filing → $100.0M
2,272,727 sh × $44.00
Exec Jun 26 2025
Filed Jun 30 2025 · 5:30 PM ET TYRAPURCHASE Tyra Biosciences, Inc. View filing → $11.8M
1,211,198 sh across 2 lots
Exec Jun 4 2025
Filed Jun 6 2025 · 5:30 PM ET ETNBPURCHASE 89bio, Inc. View filing → $50.0M
5,714,285 sh × $8.75
Exec Jan 30 2025
Filed Feb 3 2025 · 5:30 PM ET JANXPURCHASE Janux Therapeutics, Inc. View filing → $53.7M
1,200,000 sh × $44.75
Exec Oct 18 2024
Filed Oct 22 2024 · 5:30 PM ET